• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常妊娠期间、分娩时及产后的血栓调节蛋白水平:与组织型纤溶酶原激活物及纤溶酶原激活物抑制剂-1的比较

Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum: comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1.

作者信息

de Moerloose P, Mermillod N, Amiral J, Reber G

机构信息

Unité d'Hémostase, Hôpital Cantonal Universitaire, Genève, Switzerland.

出版信息

Thromb Haemost. 1998 Mar;79(3):554-6.

PMID:9531039
Abstract

Some studies suggest that soluble thrombomodulin (TM) could be used as a marker of preeclampsia or eclampsia. However little is known about the sequential changes of TM during the course of normal pregnancy. Levels of TM were determined in 100 women with uneventful pregnancies. Samples (n = 394) were divided into five study intervals, three during pregnancy, one at delivery and one three days postpartum. As compared with TM levels (median 34.3 ng/ml, range 17.6-61) of a control group of 60 healthy non-pregnant women, TM levels were shown to increase throughout pregnancy, median (and range) values being respectively 38.5 (17.6-72.7) from 11 to 20 weeks, 45.2 (22.6-75.2) from 21 to 30 weeks and 54.3 (25.1-114.5) ng/ml from 31st week to delivery. One hour after delivery TM levels were still elevated and dropped three days postpartum to 40.5 (20.9-79.4) ng/ml. The increase of TM levels was correlated with those of tissue-type plasminogen activator and plasminogen activator inhibitor-1 antigens. The large overlap in TM levels between the study periods seems to preclude a clinical use of TM based on reference values from a control group. Our data suggest that it would be more appropriate to take into account TM baseline values in a given woman to examine her TM increase during pregnancy.

摘要

一些研究表明,可溶性血栓调节蛋白(TM)可作为先兆子痫或子痫的标志物。然而,对于正常妊娠过程中TM的连续变化知之甚少。对100例妊娠顺利的女性测定了TM水平。样本(n = 394)分为五个研究时间段,三个在孕期,一个在分娩时,一个在产后三天。与60名健康非妊娠女性对照组的TM水平(中位数34.3 ng/ml,范围17.6 - 61)相比,TM水平在整个孕期均升高,11至20周时中位数(及范围)值分别为38.5(17.6 - 72.7),21至30周时为45.2(22.6 - 75.2),第31周直至分娩时为54.3(25.1 - 114.5)ng/ml。分娩后1小时TM水平仍升高,产后三天降至40.5(20.9 - 79.4)ng/ml。TM水平的升高与组织型纤溶酶原激活物和纤溶酶原激活物抑制剂-1抗原的水平相关。研究时间段之间TM水平的大量重叠似乎排除了基于对照组参考值对TM进行临床应用。我们的数据表明,考虑特定女性的TM基线值以检查其孕期TM的升高更为合适。

相似文献

1
Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum: comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1.正常妊娠期间、分娩时及产后的血栓调节蛋白水平:与组织型纤溶酶原激活物及纤溶酶原激活物抑制剂-1的比较
Thromb Haemost. 1998 Mar;79(3):554-6.
2
Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.关于正常妊娠、分娩及产褥期子宫胎盘循环中激肽释放酶-激肽系统的凝血-纤溶系统研究。
Agents Actions Suppl. 1992;38 ( Pt 2):320-9.
3
[Study on thrombomodulin and plasminogen activator inhibitor type-1 in patients of pregnancy induced hypertension].[妊娠高血压患者血栓调节蛋白及纤溶酶原激活物抑制物-1的研究]
Zhonghua Fu Chan Ke Za Zhi. 1999 Dec;34(12):712-4.
4
Enhanced PAI-1 levels from early second trimester and during labour and plasminogen activators in normal pregnancy.正常妊娠中孕早期、分娩期间纤溶酶原激活物及PAI-1水平升高。
Thromb Haemost. 2002 Jan;87(1):175-6.
5
Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy.孕前、孕期及产后血液中纤溶酶原激活剂及其抑制剂的浓度。
Eur J Obstet Gynecol Reprod Biol. 2006 Sep-Oct;128(1-2):22-8. doi: 10.1016/j.ejogrb.2006.02.004. Epub 2006 Apr 11.
6
Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.1型糖尿病孕妇的凝血和纤溶变量
Med Sci Monit. 2008 Nov;14(11):CR574-9.
7
Coagulation and fibrinolysis parameters in normal pregnancy and in gestational diabetes.正常妊娠和妊娠期糖尿病中的凝血与纤溶参数。
Am J Perinatol. 1998 Aug;15(8):479-86. doi: 10.1055/s-2007-994069.
8
Plasma thrombomodulin in orthotopic liver transplantation.
Transplantation. 1994 Dec 27;58(12):1352-5.
9
Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy.孕期组织纤溶酶原激活物水平随血浆纤维蛋白原浓度变化。
Ann Hematol. 2002 Nov;81(11):611-5. doi: 10.1007/s00277-002-0549-1. Epub 2002 Oct 23.
10
The role of fibrinolytic and antifibrinolytic activities in the pathophysiology of HELLP syndrome.
Hypertens Pregnancy. 2011;30(3):275-86. doi: 10.3109/10641950902968718. Epub 2009 Nov 27.

引用本文的文献

1
Circulating Thrombomodulin: Release Mechanisms, Measurements, and Levels in Diseases and Medical Procedures.循环血栓调节蛋白:释放机制、检测方法以及在疾病和医疗程序中的水平
TH Open. 2022 Jul 11;6(3):e194-e212. doi: 10.1055/a-1801-2055. eCollection 2022 Jul.
2
Changes in Coagulation and Fibrinolysis in Post-Cesarean Section Parturients Treated With Low Molecular Weight Heparin.低分子肝素治疗剖宫产术后产妇凝血和纤溶的变化。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620978809. doi: 10.1177/1076029620978809.
3
Tissue factor-dependent thrombin generation across pregnancy.
组织因子依赖性凝血酶生成贯穿整个妊娠过程。
Am J Obstet Gynecol. 2012 Aug;207(2):135.e1-6. doi: 10.1016/j.ajog.2012.05.027. Epub 2012 Jun 11.
4
The role of endothelial cell injury in thrombotic microangiopathy.内皮细胞损伤在血栓性微血管病中的作用。
Am J Kidney Dis. 2010 Dec;56(6):1168-74. doi: 10.1053/j.ajkd.2010.06.006. Epub 2010 Sep 16.
5
The cost-benefit ratio of screening pregnant women for thrombophilia.对孕妇进行血栓形成倾向筛查的成本效益比。
Blood Transfus. 2007 Nov;5(4):189-203. doi: 10.2450/2007.0022-07.
6
Pathophysiology and maternal biologic markers of preeclampsia.子痫前期的病理生理学及母体生物学标志物
Endocrine. 2002 Oct;19(1):113-25. doi: 10.1385/ENDO:19:1:113.